HIV Self-testing Kits Prices Slashed In Half: Vital Tool To Help People Know Their Status 28/04/2021 Chandre Prince JOHANNESBURG – A new agreement to slash the price of HIV self-tests in half could ultimately assist eight million people estimated to be unaware of their HIV status to know they are infected – and get them on treatment. The agreement announced on Wednesday between the Geneva-based international health agency, Unitaid, and the US-based global […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Emergency Committee To Member States: “Do Not Require Proof of Vaccination” As Condition Of International Travel 19/04/2021 Elaine Ruth Fletcher After months of stalemate, WHO looks set to update its guidance on managing COVID-19 infections in the context of international travel – but proof of vaccination should not be required as a condition of entry to any country, emphasized WHO’s International Health Emergency Committee. This was among the wide-ranging recommendations issued on Monday by the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Posts navigation Older Posts Newer Posts